Polycythemia vera
Polycythemia vera (abbreviated as true erythrocythemia) is a clonal chronic myeloproliferative disease with predominantly erythrocytosis accompanied by leukocytosis and thrombocytosis. The total blood volume is absolutely increased and the blood is viscous. The clinical manifestations include red and purple skin, dizziness, headache, hypertension, hepatosplenomegaly, and severe patients may develop vascular and neurological complications such as bleeding and infarction.
-
Site of disease:
Bone marrow blood vessels -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Bleeding tendency epistaxis erythrocytosis diplopia erythrocytosis -
Concurrent disease:
Related Drugs
Sodium phosphate [32P] salt oral solution
Indication: It is used to treat polycythemia vera, essential thrombocythemia and other diseases. It can also be made into external application to treat skin diseases.
Manufacturer:
HTA Co., Ltd.
Sodium phosphate [32P] salt oral solution
Indication: It is used to treat polycythemia vera, essential thrombocythemia and other diseases. It can also be made into external application to treat skin diseases.
Manufacturer:
HTA Co., Ltd.
Sodium phosphate [32P] salt oral solution
Indication: It is used to treat polycythemia vera, essential thrombocythemia and other diseases. It can also be made into external application to treat skin diseases.
Manufacturer:
HTA Co., Ltd.
Sodium phosphate [32P] salt oral solution
Indication: It is used to treat polycythemia vera, essential thrombocythemia and other diseases. It can also be made into external application to treat skin diseases.
Manufacturer:
HTA Co., Ltd.
Busulfan Injection
Indication: It is mainly used in the chronic phase of chronic myeloid leukemia, and has poor effects on patients lacking the Philadelphia chromosome Ph1. It can also be used to treat chronic myeloproliferative diseases such as essential thrombocythemia and polycythemia vera.
Melphalan Tablets
Indication: 1. Melphalan tablets are suitable for the treatment of multiple myeloma and advanced ovarian adenocarcinoma. 2. Melphalan, used alone or in combination with other drugs, has a significant effect on some patients with advanced breast cancer. 3. Melphalan is effective for some patients with polycythemia vera. Melphalan has also been used as an adjuvant drug for surgical treatment of breast cancer.
Homoharringtonine for injection
Indication: This product is an anti-tumor drug. It is suitable for the induction remission and continued treatment stages of various types of acute non-lymphocytic leukemia, especially for acute promyelocytic leukemia, acute monocytic leukemia, and acute granulocytic leukemia. It also has a certain effect on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Manufacturer:
Xi'an Disai Biopharmaceutical Co., Ltd.
Homoharringtonine for injection
Indication: This product is an anti-tumor drug. It is suitable for the induction remission and continued treatment stages of various types of acute non-lymphocytic leukemia, especially for acute promyelocytic leukemia, acute monocytic leukemia, and acute granulocytic leukemia. It also has a certain effect on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Manufacturer:
Xi'an Disai Biopharmaceutical Co., Ltd.
Homoharringtonine Sodium Chloride Injection
Indication: It is suitable for the induction remission and continued treatment stages of various types of acute non-lymphocytic leukemia, especially for acute promyelocytic leukemia, acute monocytic leukemia, and acute myeloid leukemia. It also has certain effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia, and polycythemia vera.
Manufacturer:
Shandong Qidu Pharmaceutical Co., Ltd.
Homoharringtonine Sodium Chloride Injection
Indication: It is suitable for the induction remission and continued treatment stages of various types of acute non-lymphocytic leukemia, especially for acute promyelocytic leukemia, acute monocytic leukemia, and acute myeloid leukemia. It also has certain effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia, and polycythemia vera.
Manufacturer:
Gansu Fuzheng Pharmeceutical SCI & Tech Co., Ltd.
Related Ingredients